Range
1.83 - 2.14
Vol / Avg.
1.2M/4.8M
Div / Yield
-
52 Wk
1.83 - 10.87
Mkt Cap
23M
Payout Ratio
-
Open
2
P/E
-
EPS
-0.21
Shares
11M
Outstanding
11M
Total Float
10M
Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-02-19
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Context Therapeutics Questions & Anwsers

Q

How do I buy Context Therapeutics (CNTX) stock?

A

You can purchase shares of Context Therapeutics (NASDAQ: CNTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Context Therapeutics's (CNTX) competitors?

A

There are no as such competitors for Context Therapeutics.

Q

What is the target price for Context Therapeutics (CNTX) stock?

A

There is no analysis for Context Therapeutics

Q

Current Stock Price for Context Therapeutics (CNTX)?

A

The stock price for Context Therapeutics (NASDAQ: CNTX) is $2.1 last updated Fri Jan 21 2022 21:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Context Therapeutics (CNTX) pay a dividend?

A

There are no upcoming dividends for Context Therapeutics.

Q

When is Context Therapeutics (NASDAQ:CNTX) reporting earnings?

A

Context Therapeutics’s $Q4 earnings are confirmed for after-market on February 19, 2022.

Q

Is Context Therapeutics (CNTX) going to split?

A

There is no upcoming split for Context Therapeutics.

Q

What sector and industry does Context Therapeutics (CNTX) operate in?

A

Context Therapeutics is in the sector and industry. They are listed on the NASDAQ.